Brainstorm Cell Therapeutics (BCLI) P/E (2010 - 2026)
Brainstorm Cell Therapeutics (BCLI) P/E from Dec 31, 2010 to Jul 21, 2026. The TTM Brainstorm Cell Therapeutics (BCLI) P/E is -1.03. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Brainstorm Cell Therapeutics (BCLI)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.03 | +97.82% |
| 2025 | -0.52 | -49.03% |
| 2024 | -1.02 | +59.59% |
| 2023 | -0.64 | -72.72% |
| 2022 | -2.35 | -60.43% |
| 2021 | -5.94 | +32.94% |
| 2020 | -4.47 | +8.66% |
| 2019 | -4.11 | -20.91% |
| 2018 | -5.20 | -58.71% |
| 2017 | -12.60 | +52.54% |
| 2016 | -8.26 | +32.46% |
| 2015 | -6.24 | -15.12% |
| 2014 | -7.35 | +107.94% |
| 2013 | -3.53 | -50.38% |
| 2012 | -7.12 | -26.25% |
| 2011 | -9.66 | +28.21% |
| 2010 | -7.53 | N/A |
Comparison Brainstorm Cell Therapeutics (BCLI) P/E with competitors
Brainstorm Cell Therapeutics (BCLI) P/E is -1.03.